News
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...
The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of ...
The FDA has approved the Novavax COVID-19 vaccine, called Nuvaxovid, mainly for adults 65 or older, but people ages 12 to 64 with medical conditions that increase their risk of serious illness from ...
(Reuters) -Advisers to the U.S. Food and Drug Administration will discuss whether to recommend COVID-19 vaccines for 2025-26 ...
Biopharmaceutical company BioNTech has announced funding of up to £1 billion into the UK over the next 10 years. The planned investment would be one of the biggest in the history of UK life sciences, ...
47m
Barchart on MSNModerna Is the Largest Barchart’s Bottom 100 Stocks to Buy—But Size Alone Isn’t a Reason to InvestIt’s hard to believe Moderna (MRNA)once had a market cap exceeding $204 billion. That was in August 2021 at or near the ...
47m
Asianet Newsable on MSNWHO proposes pandemic agreement to address to Covid-19 mistakes, CHECK key pointsThe WHO Pandemic Agreement, aimed at rectifying past pandemic response failures, is up for adoption. Focusing on equitable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results